Collectively, these results reveal the hypermethylation of TGFB2 mRNA, upregulation of TGF-β2 protein, and activation of TGF-β signaling pathway in FECD. The gene discussed is TGFB2; the disease is Fuchs endothelial corneal dystrophy.